Editorial Comment from Dr Matsumoto to Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatment

Saved in:
Bibliographic Details
Published in:International journal of urology 2022-10, Vol.29 (10), p.1130-1131
Main Author: Matsumoto, Kazuhiro
Format: Article
Language:English
Subjects:
Adjuvants, Immunologic - therapeutic use
Administration, Intravesical
BCG Vaccine - therapeutic use
Bladder cancer
Humans
Invasiveness
Japan
Mycobacterium bovis
Neoplasm Invasiveness
Neoplasm Recurrence, Local - drug therapy
Urinary Bladder Neoplasms - drug therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2675-34d6a87c71264d6e7e5aa3554ee288bb9e463ba7058104b560176c790fd30fcb3
container_end_page 1131
container_issue 10
container_start_page 1130
container_title International journal of urology
container_volume 29
creator Matsumoto, Kazuhiro
description
doi_str_mv 10.1111/iju.14955
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2675603244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2675603244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2675-34d6a87c71264d6e7e5aa3554ee288bb9e463ba7058104b560176c790fd30fcb3</originalsourceid><addsrcrecordid>eNp1kU1qFEEYhhtRzCS68AJS4MYsOqnf7p6ljDEmRAQx66a6-mutoX7G-pkhuxxB8BSew0u4zkmsmYkKgkXBV4unnnqLt6qeEXxCyjrVy3xC-FyIB9WMcE5rijl9WM3wnMzrjrT0oDqMcYkxYZR0j6sDJpquYVjMqp9no04-aGnQwlsLLqEpeIteB_ROppitTx6V_QGkubv9uvHBjCgFkGnHrmRKEFxE0o1IGe20Kiafk_IWIvITupQr6SDCFtXlSkQbnT4j513R2RyVAaTdWka9BjQYOY4QkJJOlRFAgV5r96kQKcg1xJ1-kEobkyNaSGOhBLi7_Xaef3wP2v2N9qR6NEkT4en9PKqu35x9XLytr96fXyxeXdWKNq2oGR8b2bWqJbQpR2hBSMmE4AC064ZhDrxhg2yx6Ajmg2gwaRvVzvE0MjypgR1VL_feVfBfMsTUWx0VGFN-7XPst680mFHOC_riH3Tpc3AlXU9bSlnDMe8KdbynVPAxBpj6VdBWhpue4H5bd1_q7nd1F_b5vTEPFsY_5O9-C3C6BzbawM3_Tf3F5fVe-QsbhL02</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2722364048</pqid></control><display><type>article</type><title>Editorial Comment from Dr Matsumoto to Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatment</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Matsumoto, Kazuhiro</creator><creatorcontrib>Matsumoto, Kazuhiro</creatorcontrib><identifier>ISSN: 0919-8172</identifier><identifier>ISSN: 1442-2042</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/iju.14955</identifier><identifier>PMID: 35686305</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Adjuvants, Immunologic - therapeutic use ; Administration, Intravesical ; BCG Vaccine - therapeutic use ; Bladder cancer ; Humans ; Invasiveness ; Japan ; Mycobacterium bovis ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local - drug therapy ; Urinary Bladder Neoplasms - drug therapy</subject><ispartof>International journal of urology, 2022-10, Vol.29 (10), p.1130-1131</ispartof><rights>2022 The Japanese Urological Association.</rights><rights>2022 The Japanese Urological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2675-34d6a87c71264d6e7e5aa3554ee288bb9e463ba7058104b560176c790fd30fcb3</cites><orcidid>0000-0001-9222-0999</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35686305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsumoto, Kazuhiro</creatorcontrib><title>Editorial Comment from Dr Matsumoto to Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatment</title><title>International journal of urology</title><addtitle>Int J Urol</addtitle><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Administration, Intravesical</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Bladder cancer</subject><subject>Humans</subject><subject>Invasiveness</subject><subject>Japan</subject><subject>Mycobacterium bovis</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local - drug therapy</subject><subject>Urinary Bladder Neoplasms - drug therapy</subject><issn>0919-8172</issn><issn>1442-2042</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kU1qFEEYhhtRzCS68AJS4MYsOqnf7p6ljDEmRAQx66a6-mutoX7G-pkhuxxB8BSew0u4zkmsmYkKgkXBV4unnnqLt6qeEXxCyjrVy3xC-FyIB9WMcE5rijl9WM3wnMzrjrT0oDqMcYkxYZR0j6sDJpquYVjMqp9no04-aGnQwlsLLqEpeIteB_ROppitTx6V_QGkubv9uvHBjCgFkGnHrmRKEFxE0o1IGe20Kiafk_IWIvITupQr6SDCFtXlSkQbnT4j513R2RyVAaTdWka9BjQYOY4QkJJOlRFAgV5r96kQKcg1xJ1-kEobkyNaSGOhBLi7_Xaef3wP2v2N9qR6NEkT4en9PKqu35x9XLytr96fXyxeXdWKNq2oGR8b2bWqJbQpR2hBSMmE4AC064ZhDrxhg2yx6Ajmg2gwaRvVzvE0MjypgR1VL_feVfBfMsTUWx0VGFN-7XPst680mFHOC_riH3Tpc3AlXU9bSlnDMe8KdbynVPAxBpj6VdBWhpue4H5bd1_q7nd1F_b5vTEPFsY_5O9-C3C6BzbawM3_Tf3F5fVe-QsbhL02</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Matsumoto, Kazuhiro</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9222-0999</orcidid></search><sort><creationdate>202210</creationdate><title>Editorial Comment from Dr Matsumoto to Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatment</title><author>Matsumoto, Kazuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2675-34d6a87c71264d6e7e5aa3554ee288bb9e463ba7058104b560176c790fd30fcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Administration, Intravesical</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Bladder cancer</topic><topic>Humans</topic><topic>Invasiveness</topic><topic>Japan</topic><topic>Mycobacterium bovis</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local - drug therapy</topic><topic>Urinary Bladder Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsumoto, Kazuhiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsumoto, Kazuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial Comment from Dr Matsumoto to Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatment</atitle><jtitle>International journal of urology</jtitle><addtitle>Int J Urol</addtitle><date>2022-10</date><risdate>2022</risdate><volume>29</volume><issue>10</issue><spage>1130</spage><epage>1131</epage><pages>1130-1131</pages><issn>0919-8172</issn><issn>1442-2042</issn><eissn>1442-2042</eissn><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35686305</pmid><doi>10.1111/iju.14955</doi><tpages>1131</tpages><orcidid>https://orcid.org/0000-0001-9222-0999</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0919-8172
ispartof International journal of urology, 2022-10, Vol.29 (10), p.1130-1131
issn 0919-8172
1442-2042
1442-2042
language eng
recordid cdi_proquest_miscellaneous_2675603244
source Wiley-Blackwell Read & Publish Collection
subjects Adjuvants, Immunologic - therapeutic use
Administration, Intravesical
BCG Vaccine - therapeutic use
Bladder cancer
Humans
Invasiveness
Japan
Mycobacterium bovis
Neoplasm Invasiveness
Neoplasm Recurrence, Local - drug therapy
Urinary Bladder Neoplasms - drug therapy
title Editorial Comment from Dr Matsumoto to Real‐world treatment patterns and clinical outcomes of Japanese patients with non‐muscle invasive bladder cancer receiving intravesical bacillus Calmette–Guérin treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A54%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial%20Comment%20from%20Dr%20Matsumoto%20to%20Real%E2%80%90world%20treatment%20patterns%20and%20clinical%20outcomes%20of%20Japanese%20patients%20with%20non%E2%80%90muscle%20invasive%20bladder%20cancer%20receiving%20intravesical%20bacillus%20Calmette%E2%80%93Gu%C3%A9rin%20treatment&rft.jtitle=International%20journal%20of%20urology&rft.au=Matsumoto,%20Kazuhiro&rft.date=2022-10&rft.volume=29&rft.issue=10&rft.spage=1130&rft.epage=1131&rft.pages=1130-1131&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/iju.14955&rft_dat=%3Cproquest_cross%3E2675603244%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2675-34d6a87c71264d6e7e5aa3554ee288bb9e463ba7058104b560176c790fd30fcb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2722364048&rft_id=info:pmid/35686305&rfr_iscdi=true